Drug for celiac disease shows promise in treating severe post-COVID syndrome in children
In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID.
Jul 30, 2025
0
153









